ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL CANCER INSTITUTE

Microfluidic immunotherapy screening on a core needle biopsy

Active
Institution
UNIVERSITY OF ILLINOIS AT CHICAGO, IL
Principal investigator
Steve Seung-Young Lee
Funding
$386K
Duration
2025–2027
Open portfolio

Moonbase score

Still being scored

Abstract

Project Abstract We propose to develop a microfluidic device for direct personalized immunotherapy screening on a core need biopsy. Since a number of various immunotherapy have been approved for cancer treatment, it is crucial to select the right treatment among many immunotherapy options for a successful cancer therapy. Although tissue microfluidic devices have shown potential as chemotherapy screening tools, none are suitable for personalized immunotherapy screening. In this project, we will 1) develop a ‘core needle biopsy’ microfluidic cassette and protocols for functional immune assays and 2) validate the microfluidic approach for screening immune checkpoint blockade therapy with core needle biopsies from mouse and PDX breast tumors. We believe the microfluidic immunotherapy screening on individual cancer patients’ tumor core biopsies will provide solid guidance to oncologists in choosing the right immunotherapies for their patients.

LOADING MOONBASE SCORE

NATIONAL CANCER INSTITUTER21Special Emphasis Panel[ZRG1 BBBT-T (82)]screeningimmunotherapyneedlemicrofluidic devicesbiopsyrightmicrofluidicbiopsies

Questions for UNIVERSITY OF ILLINOIS AT CHICAGO

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.